CLINICAL_TRIALS
trial_result
· 2024-10-10
Clinical Trial Update: AZD8601 Study in CABG Patients [Phase 2]
Summary
A Phase 2 trial of AZD8601 in CABG patients with heart failure has completed, with results posted in October 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2024-10-10